Further, it is noteworthy that AXL is reportedly overexpressed in prostate cancer cell lines and human prostate tumors [42], and its expression is considerably higher in more aggressive androgen-refractory PC3 and DU145 cells compared with the androgen-dependent cell line LNCaP [43]. The gene discussed is AXL; the disease is prostate cancer.